CIK 0001111485 · Accelerated filer
RxSight, Inc.
Sign in to watch- Ticker
- RXST
- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943268801
- Phone
- 949-521-7822
- Business address
- 100 COLUMBIA STREET, SUITE 120, ALISO VIEJO, CA, 92656
- Former names
- CALHOUN VISION INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,951
- in 4 filings
Net −$117,951. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-05 | Kurtz Ronald M MD Chief Medical Officer | Grant or award · Stock Option (right to buy) | +96,129 | 96,129 | ||
| 2026-09-05 | Kurtz Ronald M MD Chief Medical Officer | Grant or award · Stock Option (right to buy) | +161,654 | 161,654 | ||
| 2026-09-05 | Goldshleger Ilya Chief Operating Officer | Returned to the company · Stock option (right to buy) | −98,367 | 0 | ||
| 2026-09-05 | Goldshleger Ilya Chief Operating Officer | Returned to the company · Stock Option (right to buy) | −120,000 | 0 | ||
| 2026-09-05 | Goldshleger Ilya Chief Operating Officer | Returned to the company · Stock Option (right to buy) | −92,200 | 0 | ||
| 2026-09-05 | Goldshleger Ilya Chief Operating Officer | Returned to the company · Stock Option (right to buy) | −50,000 | 0 | ||
| 2026-09-05 | Goldshleger Ilya Chief Operating Officer | Returned to the company · Stock Option (right to buy) | −125,000 | 0 | ||
| 2026-09-05 | Goldshleger Ilya Chief Operating Officer | Grant or award · Stock Option (right to buy) | +73,960 | 73,960 | ||
| 2026-09-05 | Goldshleger Ilya Chief Operating Officer | Grant or award · Stock Option (right to buy) | +104,347 | 104,347 | ||
| 2026-09-05 | Goldshleger Ilya Chief Operating Officer | Grant or award · Stock Option (right to buy) | +59,483 | 59,483 | ||
| 2026-09-05 | Goldshleger Ilya Chief Operating Officer | Grant or award · Stock Option (right to buy) | +32,258 | 32,258 | ||
| 2026-09-05 | Goldshleger Ilya Chief Operating Officer | Grant or award · Stock Option (right to buy) | +93,984 | 93,984 | ||
| 2026-09-02 | Kurtz Ronald M MD Chief Medical Officer | Sale | −5,100 | $6.96 | $35K | 71,775 |
| 2026-09-02 | Wilterding Mark Chief Financial Officer | Sale | −7,765 | $6.96 | $54K | 25,049 |
| 2026-09-02 | Goldshleger Ilya Chief Operating Officer | Sale | −2,041 | $6.96 | $14K | 81,509 |
| 2026-09-02 | Weinberg Eric See remarks | Sale | −2,041 | $6.96 | $14K | 200,348 |
| 2026-08-31 | Kurtz Ronald M MD Chief Medical Officer | Option exercise | +13,425 | 76,875 | ||
| 2026-08-31 | Kurtz Ronald M MD Chief Medical Officer | Option exercise · Restricted Stock Unit | −13,425 | 67,120 | ||
| 2026-08-31 | Wilterding Mark Chief Financial Officer | Option exercise | +20,441 | 32,814 | ||
| 2026-08-31 | Wilterding Mark Chief Financial Officer | Option exercise · Restricted Stock Unit | −20,441 | 122,646 |
Page 2 of 15 · 300 trades